annb0t
Top 20
Mesoblast Limited
NEW YORK, Feb. 26, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the second quarter ended December 31, 2022.
The webcast will begin at 4.30pm EST, Monday, February 27; 8.30am AEDT, Tuesday, February 28; 2023. It can be accessed via: https://webcast.openbriefing.com/msb-qtr-2023/
The archived webcast wil...
>>> Read more: Mesoblast Financial Results and Corporate Update Webcast
NEW YORK, Feb. 26, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the second quarter ended December 31, 2022.
The webcast will begin at 4.30pm EST, Monday, February 27; 8.30am AEDT, Tuesday, February 28; 2023. It can be accessed via: https://webcast.openbriefing.com/msb-qtr-2023/
The archived webcast wil...
>>> Read more: Mesoblast Financial Results and Corporate Update Webcast
